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Aerial surveys have been carried out by the Sea
Mammal Research Unit, to monitor harbour seal
Phoca vitulina populations around Scotland since
1985, and declines in a number of these populations
have been seen since 2000 (Lonergan et al. 2007).
Major declines of 68% in Orkney, 50% in Shetland,
and 90% in the Firth of Tay have been documented
in particular (SCOS 2012). However, the pattern of
the declines is not universal, as some areas remain
more stable while the populations in other areas con-
tinue to decrease in size. The population in the Eden
and Firth of Tay Special Area of Conservation, for
example, has experienced the most dramatic and
sustained de clines of over 90% in the last 15 yr, with
a most recent estimate of just 29 individuals left in
2014 (Hanson et al. 2017).
Many potential causes of the decline have been
suggested, but the contributing factors remain un -
certain. Some of these include predation by killer
whales (Bolt et al. 2009), competition for food with
other marine top predators (SCOS 2012), exposure to
biotoxins from harmful algal blooms (Hall & Frame
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ABSTRACT: Since 2000 there has been a major decline in the abundance of Scottish harbour seals
Phoca vitulina. The causes of the decline remain uncertain. The aim of this study was to establish
the extent to which the seals in the regions of greatest decline have been exposed to Brucella, a
bacterial pathogen that causes reproductive failure in terrestrial mammalian hosts. Tissues from
dead seals collected between 1992 and 2013 were cultured for Brucella (n = 150). Serum samples
collected from live capture−released seals (n = 343) between 1997 and 2012 were tested for
 Brucella antibodies using the Rose Bengal plate agglutination test (RBT) and a competitive
enzyme-linked immunosorbent assay (cELISA). In total, 16% of seals cultured had Brucella iso-
lated from one or more tissues, but there were no pathological signs of infection. The cELISA
results were more sensitive than the RBT results, showing that overall 25.4% of seals were
seropositive, with the highest seroprevalence in juveniles. As there was no evidence of either a
higher seroprevalence or higher circulating antibody levels in seropositive animals in the areas
with the greatest declines, it was concluded that Brucella infection is likely not a major contribut-
ing factor to recent declines. However, the consistently high proportion of seals exposed to
 Brucella indicates possible endemicity in these populations, likely due to B. pinnipedialis, which
has demonstrated a preference for pinniped hosts. Importantly, given the close proximity between
seals, humans and livestock in many areas, there is the potential for cross-species infections.
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2010), deliberate shooting (Thompson et al. 2007),
accidental mortalities as a result of interactions with
shipping vessels (Thompson et al. 2010) and preda-
tion by grey seals Halichoerus grypus (Brownlow et
al. 2016). A further potential contributing factor to
these declines is infectious disease, but there has
been a lack of reports of sick animals by the Scottish
Marine Animals Strandings Scheme (SMASS) or the
Scottish Society for the Prevention of Cruelty to Ani-
mals (SSPCA). This suggests that if infectious disease
was present in these populations, and was contribut-
ing to the observed declines, it could either be affect-
ing the reproductive success of the animals, or caus-
ing them to die very quickly once infected, or both. A
particular infectious agent of interest in this respect is
Brucella as it is known to cause reproductive failure
in other mammalian hosts. The aim of this study was
to establish the extent to which harbour seals in Scot-
land have been exposed to Brucella over time, both
before and during the observed population declines,
and whether this could be a potential contributing
factor to the major declines in some areas.
Members of the genus Brucella are Gram-nega-
tive, rod-shaped bacteria that cause chronic disease
most commonly associated with abortions and infer-
tility in domestic livestock (Seleem et al. 2010). Since
the first reports of Brucella in a marine mammal in
1994 (Ross et al. 1994), infections have been recog-
nised in a range of pinniped and cetacean species
worldwide (Thakur et al. 2012). Strains isolated from
marine mammals have been shown to be pheno -
typically and genetically distinct from those isolated
from terrestrial mammals, and 2 species have been
described that have pinnipeds and cetaceans as their
preferred hosts: B. pinnipedialis and B. ceti, respec-
tively (Foster et al. 2007). B. ceti infections in ceta -
ceans have been associated with various patho logies
which include abortions and neonatal mortality
(Miller et al. 1999), epididymitis in males (Da gleish et
al. 2008), meningoencephalitis (González et al. 2002,
Jauniaux et al. 2010, Alba et al. 2013, Garofolo et al.
2014), abscesses (Foster et al. 1996, Foster et al.
2002), endocarditis (González-Barrientos et al. 2010),
mastitis, pneumonia, peritonitis, osteomyelitis and
spinal discospondylitis (Foster et al. 2002). In con-
trast, pathology associated with B. pinnipedialis in
seals is lacking despite several reports of its isolation
(Foster et al. 2002, Tryland et al. 2005, Nymo et al.
2011, Siebert et al. 2017).With respect to harbour
seals specifically, Brucella has previously been iso-
lated from wild animals (Ross et al. 1994, Garner et
al. 1997, Foster et al. 2002, Prenger-Berninghoff et al.
2008), and in several areas they have also been found
to be seropositive (Ross et al. 1996, Maratea et al.
2003, Gaydos et al. 2005, Hueffer et al. 2013). How-
ever, the extent to which harbour seals in Scotland, or
the United Kingdom in general, have been exposed
to this pathogen since the onset of the de clines is
unknown. Here, tissue samples from dead harbour
seals collected by the SMASS over 20 yr were cul-
tured to test for Brucella isolates. In addition, harbour
seal serum samples from live capture− release studies
by the Sea Mammal Research Unit over a 14 yr
period were tested for Brucella antibodies.
Tempo–spatial patterns in seroprevelance were
examined in order to investigate the potential role of




Tissue samples from 150 dead harbour seals from
across Scotland which had received post mortem
examination were collected by the SMASS between
1992 and 2013 as part of systematic surveillance
studies. Microbiological culture was performed, in -
cluding specific methods for Brucella isolation. The
selected tissues varied between animals but typically
included lung, liver, kidney, spleen and small intes-
tine, but also brain, pancreas, reproductive tissue,
various lymph nodes and any abscesses apparent at
post mortem. These were collected from approxi-
mately equal numbers of males (n = 61), females (n =
41) and unsexed animals (n = 48). The majority of
cases were adult animals although some juveniles
were also sampled. Tissues were processed using a
standardised method (Foster et al. 2002) and cultured
on Columbia sheep blood agar (CSBA; Oxoid) and
Farrell’s medium incubated at 37°C in air with 5%
added CO2. Isolates with colonial ap pearance typical
of Brucella on either medium were identified as Bru-
cella using phenotypic tests as previously described
(Foster et al. 2002). A multi-locus variable number of
tandem repeats analysis (MLVA-16) was used to con-
firm species designation (Ma quart et al. 2009).
Serum sampling procedure
Blood samples were collected from 343 live-cap-
tured harbour seal adults, juveniles (<50 kg and/or
120 cm) and suckling pups from multiple haul out
sites around 5 areas of Scotland: the South East (the
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Eden Estuary, the Firth of Tay and the Firth of Forth),
the North East (the Moray Firth, Dornoch Firth, Loch
Fleet and the Pentland Firth), the North West (the Isle
of Skye, Loch Shieldaig, and the Loch Nan Uamh
Islands), the South West (the Sound of Jura and south
east Islay), and Orkney (Fig. 1). Samples were col-
lected between 1997 and 2012 at varying times of the
year. Due to the opportunistic nature of the analysis
of stored samples, sample sizes varied regionally,
across years and between age classes, although the
male to female ratio was approximately equal with
182 males and 160 females (Table 1). The seals were
captured in nets on haul outs or in the water, and
were sedated with Zoletil 100 (Virbac) at a dose rate
of 0.5 ml per 100 kg body weight intravenously.
Blood samples were taken from the extradural vein
immediately after the immobilisation of the animal.
The whole blood samples were spun, sera was col-
lected, and aliquots were frozen at −20°C for later
analysis. Samples were collected under the Animal
(Scientific Procedures) Act, 1986, Home Office Pro-
ject and Personal Licences issued to the Sea Mammal
Research Unit.
Serological methods
In a preliminary trial, the Rose Bengal plate agglu-
tination test (RBT) was used to test stored serum sam-
ples for the presence of Brucella antibodies. Serum
samples were tested with the Micropath Rose Bengal
kit against the B. abortus antigen (Omega Diagnos-
tics) following the kit instructions. Samples were
either classed as positive or negative based on visu-
ally discernible agglutination of antigens. A positive
and a negative control supplied by the kit were used
for each set of 4 serum samples tested simultane-
ously.
Following the completion of the Rose Bengal trials
with the successful detection of antibodies, the varia-
tion in seroprevalence, i.e. the proportion of animals
with antibody levels higher than a background
threshold level set for terrestrial mam-
mals, as well as the absolute antibody
levels in the samples, were investigated
using a competitive ELISA (cELISA).
Here, polystyrene microtitre plates were
coated with Brucella melitensis lipo -
polysaccharide (LPS) antigen. Both posi-
tive (positive serum from an experimen-
tally infected goat with B. melitensis)
and negative con trols (no sera) were
tested. Serum and a peroxidase-labelled
monoclonal anti body (BM40 from a
locally held hy bridoma) were added to
the plates and incubated for 30 min at
room temperature. The plate was then
washed, and chromogen and substrate
were added and incubated for a further
15 min at room tempe rature, shaking at
160 rpm. The plates were read at an
optical density (OD) of 450 nm. The
mean OD of duplicate wells was ex -
pressed as a percentage of antibodies
binding to the plate. Test samples with
an OD of less than 60% of the conju-
gate-only control (no sera added) were
recorded as positive. This cut-off thresh-
old was established based on serology
results from terrestrial mammals (Perrett
et al. 2010). As such, a weak reaction,
indicative of low antibody levels, was
considered to be between 30 and 60%
antibody binding, while a strong reac-
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Fig. 1. Sampling regions of live-captured harbour seals across Scotland be-
tween 1997 and 2012 by the Sea Mammal Research Unit. Serum samples
were grouped into 5 main regions across Scotland as indicated by the cir-
cles on the map. Over this time period, the populations along the west coast,
marked as ‘North West’ and ‘South West’ were stable while the populations
in ‘Orkney’, the ‘North East’ and the ‘South East’ underwent precipitous 
declines (SCOS 2012)
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tion, indicative of high circulating antibody levels,
was considered to be <30%.
Statistical analysis of serological data
All statistical analyses were performed using the
statistical package R, version 3.1.2 (R Core Devel-
opment Team 2014). Results were considered sta-
tistically significant at p ≤ 0.05. Two different statis-
tical approaches were taken to investigate firstly,
variation in the seroprevalence data, and secondly,
variation in the antibody levels in the seropositive
individuals.
For the seroprevalence data, generalised linear
models (GLMs) with a binomial distribution were
 fitted to the seroprevalence data with individuals
classed as seropositive (1) and seronegative (0) for the
2 tests separately. The 14 yr of data were split into 4
time periods: 1997 to 2000 (n = 63) represents the
years before the start of the decline, and the years be-
tween 2001 and 2012 were split into 3
periods with approximately equal num-
bers of samples in each to give the
maximum statistical power for the
analysis. These were 2001 to 2005 (n =
87), 2006 to 2008 (n = 94) and 2009 to
2012 (n = 99). A global model including
all explanatory variables of interest (re-
gion, sex, age class, time period and an
interaction between region and time
period) was generated, and backwards
variable selection using the ‘step’ func-
tion in the ‘car’ library in R v.2.11.1 was
performed to identify the combination
of variables that best explained the
variation in the data by producing the
model with the lowest Akaike’s infor-
mation criterion (AIC) value.
In addition, variation in the levels of
circulating Brucella antibodies were
investigated in the seropositive indi-
viduals identified using the cELISA
data. Antibody binding results of only
the seropositive seals were modelled
using a GLM with a gamma distribu-
tion and a log-link function to model
the non-normal distribution of the
antibody binding data, as most indi-
viduals had low circulating antibody
levels while few were very high.
Again, a global model with region,
sex, age class, time and an interaction
between region and time was generated and back-
wards variable selection using the ‘step’ function was
used to identify the combination of variables that
best explained the variation in the data.
RESULTS
Brucella cultures
Of the 150 animals examined bacteriologically be -
tween 1992 and 2013, Brucella was isolated from the
tissues of 24 individuals (16%). Details for 11 of these
animals have been reported previously (Foster et al.
2002). None of the culture-positive animals showed
any signs of pathological lesions associated with
infection, and the cause of death was always associ-
ated with starvation, trauma or some other viral or
bacterial infection, but not Brucella. Of the tissues
cultured, the 2 that were the most commonly culture-
positive were lung (45.8%) and spleen (41.7%),
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Sampling Sex Age Serological samples collected by region
period class North North Orkney South South 
East West East West
1997−2000 Male Adults − − − 37 −
Juveniles − − − 1 −
Pups − − − 3 −
Female Adults − − − 21 −
Juveniles − − − 1 −
Pups − − − − −
2001−2005 Male Adults 5 − 11 15 14
Juveniles − − − 1 −
Pups − − − − −
Female Adults 10 − 12 9 4
Juveniles 1 − − 2 2
Pups − − − − 1
2006−2008 Male Adults 3 1 10 16 8
Juveniles − − − − 1
Pups − − − − 5
Female Adults 7 1 15 6 7
Juveniles 1 − − − −
Pups 2 − 11 − −
2009−2012 Male Adults 1 14 21 10 2
Juveniles 1 − 1 − 1
Pups − − − − −
Female Adults 6 11 20 1 8
Juveniles 1 − − − 1
Pups − − − − −
Table 1. Serological samples collected from harbour seals across the 5 sam-
pling regions of Scotland and over 12 yr broken down into 4 time periods.
Samples are grouped by sex and age class. A total of 306 adults, 15 juveniles 
and 22 pups were sampled
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although not all tissues were sampled consistently
across individuals (Table 2). MLVA-16 analysis iden-
tified isolates as B. pinnipedialis be longing to 1 of 2
sequence types: ST 24 or ST 25. Serum was sampled
from 12 of these culture-positive seals, 2 of which
were seronegative and were sampled from healthy
animals that had been shot (Table 2).
Serology
Test performance
The RBT trials were able to detect antibodies in the
archived serum samples, and results showed that
across all study sites over the whole sampling period,
the prevalence of Brucella antibodies was 15.9%.
However, the cELISA results showed a higher overall
seroprevalence of 25.4%. The prevalence across all
age and sex classes, as well as across regions and
over time was lower for the RBT results compared to
the cELISA results (Table 3).
All of the samples that were positive using the RBT
were also classed as positive using the cELISA.
These samples had the lowest antibody binding indi-
cating the highest circulating Brucella antibodies.
Specifically, the mean antibody binding of the sam-
ples classed as positive by the RBT was 45.0 ± 0.06%,
17
Reference no.            Positive cultures                                                    Negative cultures
M2357/93                  Spleen                                                                    Lung, liver
M2466/93                  Spleen                                                                    Lung, MLN
M2533/93                  Spleen                                                                    MLN, SI
M292/94*                  Spleen                                                                    Testes, MLN, SI
M336/94*                  IILN                                                                        Spleen, MLN
M339/94                    GLN                                                                        Spleen, IILN
M972/94                    EILN, manLN                                                        Spleen, MLN
M490/95                    EILN, HLN, IILN, TLN                                          Lung, spleen, brain, CRLN, GLN, manLN, blood, SI
M514/96                    Lung                                                                       
M445/99                    Lung                                                                       Liver, spleen, kidney, brain, MLN, blood, SI
M13/01                      Lung                                                                       Liver, spleen, kidney, blood
M250/02                    Lung, liver, spleen, kidney, MLN, blood             Brain, SI
M305/02                    Spleen                                                                    Lung, liver, kidney, brain, MLN, cellulitis, SI
M342/02                    MLN                                                                       Lung, liver, spleen, kidney, brain, blood
M374/02                    Lung, liver, spleen, kidney                                   Brain, MLN
M449/02                    Lung                                                                       
M599/02                    MLN                                                                       Lung, liver, spleen, kidney
M43/09                      Lung, liver, spleen, kidney, MLN, SI                   
M91/10                      Lung, brain                                                            Liver, spleen, kidney, MLN
M228/10                    Pancreas                                                                 Lung, liver, spleen, kidney, brain, MLN, SI
M244/10                    Lung, liver, spleen, brain, MLN, SI                      Kidney
M273/10                    Lung, MLN                                                            Liver, spleen, kidney, brain, pre-scapular LN, SI
M341/11                    Lung, spleen, MLN, SI                                          Liver, kidney, brain, abscess
M337/13                    Kidney, brain                                                         Lung, liver, spleen
Table 2. Details of 24 Brucella culture-positive harbour seals. The last 2 digits of the reference number indicate the year of
stranding. (*) Indicates individuals that were culture-positive but seronegative. MLN: mesenteric lymph node; IILN: internal
iliac lymph node; EILN: external iliac lymph node; GLN: gastric lymph node; ManLN: mandibular lymph node; HLN: hepatic 
lymph node; TLN: thoracic lymph node; CLRN: colorectal lymph node; SI: small intestine
Variable n % of seropositive animals
RBT cELISA
Scotland 343 15.9 25.4
North East 38 28.6 28.9
North West 27 14.8 33.3
Orkney 101 12.9 28.7
South East 123 19.8 20.3
South West 54 3.9 24.1
Males 183 14.5 25.7
Females 160 17.4 24.4
Adults 306 14.5 25.2
Juveniles 15 60.0 53.3
Pups 22 4.5 9.09
1997−2000 63 12.3 22.2
2001−2005 87 24.7 26.4
2006−2008 94 12.0 18.1
2009−2012 99 13.7 33.3
Table 3. Comparison of the prevalence (% of seropositive
harbor seals) using the Rose Bengal plate agglutination test
(RBT) and the competitive ELISA (cELISA). The ELISA re-
sults indicate a higher overall prevalence of Brucella anti-
bodies in harbour seals than the RBT results
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while those classed as negative had a mean antibody
binding of 74.0 ± 0.02% (2-sample t-test; t = 8.79, df =
51.54, p < 0.0001). Therefore, it seems that the RBT is
only able to detect high antibody levels in the serum
samples and is the least sensitive of the 2 serological
methods tested. As a result, the RBT results may have
underestimated the prevalence of Brucella antibod-
ies in these harbour seals (Table 3).
Seroprevalence
Using the cELISA seroprevalence data where indi-
viduals were classed as either seropositive or sero -
negative, the best binomial GLM after backwards
variable selection included only age class as an
important explanatory variable. Juveniles had a sig-
nificantly higher seroprevalence than adults and
pups (p-values < 0.025), while adults and pups were
not significantly different from each other (p = 0.11).
There were no significant changes in prevalence
over time or between regions, and there were equal
numbers of seropositive males and females.
Antibody levels
Variation in the levels of circulating Brucella anti-
bodies were investigated in the seropositive individ-
uals. Backwards variable selection of the GLM using
the cELISA antibody binding results of only the
seropositive seals revealed that age class and an
interaction between region and time period were
retained in the final model with significant effects.
Pups had near-significant higher antibody binding
than both adults and juveniles (both p-values < 0.07),
indicating the lowest circulating antibodies in these
seropositive individuals (Fig. 2). There was no differ-
ence between the circulating antibody levels in juve-
niles and adults (Fig. 2). The interaction between
region and time revealed that there were different
patterns in circulating antibody levels in the sero -
positive seals between regions over the 14 yr sam-
pling period. The highest average circulating Brucel -
la anti body levels (shown as the lowest % anti body
binding in Fig. 3) were measured in the 2001 to 2005
time period in the South West, and these then de -
creased over the following years (p = 0.035). All areas
showed a decrease followed by an increase again
over the whole time frame, with the exception of
Orkney, which showed a sustained decrease in circu-
lating antibodies between 2001 and 2012 (Fig. 3), and
the North West, where seropositive individuals were
only recorded in the final time period, but this is
likely a reflection of very limited sampling before
2009 (Table 1) rather than a recent introduction of the
bacteria to the area. Males and females had similar
antibody levels.
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Fig. 2. Competitive ELISA (cELISA) antibody binding of the
seropositive harbour seals by age class. Lines in the boxes
represent the median values; box edges are the 25th and
75th percentiles. Low antibody binding indicates high lev-
els of circulating Brucella antibodies in the seals. Pups had
lower circulating antibody levels than both adults and 
juveniles
Fig. 3. Interaction plot of the competitive ELISA (cELISA) %
antibody binding over time for each sampling region show-
ing variation in seropositive harbour seal individuals. Low
antibody binding indicates high levels of circulating Bru-
cella antibodies in the seals. The North West sampling re-
gion is not included here as seropositive animals were only
identified in this area between 2009 and 2012. With the
 exception of Orkney, the other sampling regions showed a
decrease in the circulating levels of Brucella antibodies,
followed by an increased again over this time period
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DISCUSSION
Brucella species were isolated from 16% of the
dead stranded animals tested, but there were no
signs of Brucella-specific pathological lesions associ-
ated with infection in these 24 animals. They all ap -
pear to have died of other causes, although it is pos-
sible that Brucella acted as a secondary infection in
these cases. The results presented here therefore
suggest that harbour seals can be infected by Bru-
cella, likely B. pinnipedialis, without evidence of as -
sociated disease. B. pinnipedialis has also been cul-
tured from apparently healthy tissues of a number of
other pinniped species, including grey seals Hali-
choerus grypus (Foster et al. 2002, Prenger-Berning-
hoff et al. 2008), hooded seals Cystophora cristata
(Foster et al. 2002, Tryland et al. 2005), ringed seals
Pusa hispida (Forbes et al. 2000) and harp seals
Pagophilus groenlandicus (Forbes et al. 2000). At
present, there is only limited evidence of Brucella
infection causing disease in any species of phocid
seal (Jauniaux et al. 2013), although Brucella isola-
tion was suggested as a possible cause of abortion in
an otariid species, the California sea lion Zalophus
californianus, with recovery of Brucella from the pla-
centa and stomach contents of an aborted foetus
(Goldstein et al. 2009). Extensive typing of a large
number of marine mammal Brucella strains in a
recent study, however, found the Californian sea lion
isolates to be similar to B. ceti recovered from bottle-
nose dolphins in the USA and that B. pinnipedialis
isolates from harbour seals in the USA were found to
be closely related to Scottish strains (A. M. Whatmore
et al. unpubl. data).
Animal experimentation in cattle with a Brucella
isolate recovered from a Pacific harbour seal Phoca
vitulina richardsii resulted in seroconversion and
abortion in 2 of 3 pregnant animals, suggesting that
some strains of B. pinnipedialis may have abortifa-
cient potential (Rhyan et al. 2009). However, there
has been no evidence in pinnipeds of disease due to
B. pinnipedialis as has been seen with B. ceti infec-
tion in dolphins and porpoises where chronic disease
with significant clinical and pathological signs in -
cluding male infertility, neurobrucellosis, cardio -
pathies, bone and skin lesions and live strandings
have been documented (Guzmán-Verri et al. 2012).
While no evidence of disease has been reported in
pinnipeds, detecting abortions in wild populations is
very difficult, especially if the occurrence remains
constant over time and there is limited data on pup-
ping success, as is the case for the populations sam-
pled here. The ability to detect abortions and monitor
pupping success in different populations is therefore
needed in order to determine that B. pinnipedialis
does not cause disease in these seals.
Similar to this study, Brucella antibodies have been
detected in sera from a number of marine mammal
species using Rose Bengal tests (Tryland et al. 1999,
2005, Retamal et al. 2000, Hernández-Mora et al.
2008, Jensen et al. 2013), and using both indirect
ELISA (iELISA) and cELISAs primarily designed for
ruminants (Tryland et al. 1999, Nielsen et al. 2001,
Van Bressem et al. 2001, Tachibana et al. 2006, Roe
et al. 2010, Lynch et al. 2011, Jensen et al. 2013,
Nymo et al. 2013a). Here, differences in the preva-
lence estimates obtained from the RBT and the
cELISA results highlight the need to consider test
performance when conducting serological studies. It
seems that the RBT is only able to detect antibodies
when at higher levels, and as such, seropositive sam-
ples with low levels of antibody are not recognised.
Our results suggest that the cELISA appears to be a
more sensitive test than RBT and is thus able to dis-
tinguish between seronegative samples and samples
with low antibody levels. The cELISA results were
therefore chosen for further analysis over the RBT
results as this is thought to be a more robust and
objective test. However, when detecting Brucella
anti bodies using serological methods, serological
cross-reactions and false positives are potentially a
major problem, and may contribute to the higher
seroprevalence seen in the cELISA results. It is
thought that in cattle most problems caused by cross-
reactivity are the result of antibodies produced
through the immune response of the animal to other
microorganisms sharing similar structural character-
istics with the O-polysaccharide of Brucella species
(Corbel 1985). We cannot rule out the possibility that
other cross-reacting bacteria could affect these re -
sults. In cattle, it is thought that the cELISA is a more
appropriate serological test than the iELISA as it is
better able to distinguish between antibodies to Bru-
cella species and antibodies to other cross-reacting
Gram-negative bacteria (Nielsen 1990, Samartino et
al. 1999). In 2 studies on Australian fur seals (Lynch
et al. 2011) and Hawaiian monk seals Monachus
schauinslandi (Nielsen et al. 2005), it was concluded
that the iELISA was an unreliable test for the iden -
tification of seropositive individuals. Thus, based
on this previous evidence, the cELISA was chosen
here as an appropriate assay as it is more conserva-
tive than an iELISA with a reduced chance of false
positives.
The cELISA results indicate that approximately
25% of the seals sampled had antibodies to Brucella.
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This is within the range of previous studies on har-
bour seal populations in the North Atlantic, where
prevalence ranged between 3.1% (n = 96) in the
St Lawrence Estuary, 14% (n = 21) (Maratea et al.
2003) and 50% (n = 8) off the Atlantic coast of the
United States (Nielsen et al. 2001). Serology testing
of 300 Scottish harbour seals prior to 2002 found 147
(49%) to be positive (Foster et al. 2002). As there
appears to have been no change in antibody preva-
lence over this 14 yr sampling period, or between
regions, these data suggest that Brucella may be
endemic in Scottish harbour seals, and exposure to
the bacteria seems to have remained constant over
the study period. For endemicity to occur, a high and
regular rate of transmission of the bacteria is re -
quired within a population.
The transmission of Brucella in marine mammals is
poorly understood as there is little evidence to sup-
port any particular route of infection in these species.
It is likely that the routes of transmission are similar
to those of terrestrial mammals, whereby transmis-
sion occurs through exposure to infected placenta,
birth fluids and vaginal secretions as well as by vene-
real spread (Young 2006). As Brucella has been iso-
lated from the reproductive organs of several ceta -
cean species (Miller et al. 1999, Foster et al. 2002,
González-Barrientos et al. 2010), and from an abor -
ted foetus of a captive bottlenose dolphin (Ewalt et al.
1994), the most likely mode of transmission of B. ceti
appears to be through sexual intercourse, vertical
transmission from mother to foetus, maternal feeding
and contact with aborted foetuses and placental tis-
sues (Guzmán-Verri et al. 2012). The transmission
between pinnipeds is even less well understood, but
it could be similar to cetaceans. However, transmis-
sion may also occur through contact with infected
individuals in gregarious species that haul out
together in large groups. Brucella was cultured from
the faeces of a seropositive juvenile harbour seal in
captivity (Gaydos et al. 2005), suggesting that some
Brucella-positive seals are actively shedding the bac-
teria. In addition, B. pinnipedialis was cultured or
detected by PCR in harbour seal salivary gland
secretions, lungs, urinary bladder and faeces (Lam-
bourn et al. 2013), suggesting that seals could be
exposed to the bacterium via exposure to oral secre-
tions, urine or faeces on haul-outs. Brucella has also
been isolated from subcutaneous lesions in cetaceans
(Foster et al. 1996, 2002), so the potential for direct
contact with similarly infected skin lesions, should
they occur, in pinnipeds that haul out together may
present another mode of transfer of the bacteria,
although such lesions have not been reported to date.
Together, this could make harbour seals more at risk
of bacterial transfer at particular times during their
life cycle when they haul-out in larger numbers dur-
ing the breeding season and during the moult. Thus,
the requirements of a high and regular rate of trans-
mission of the bacteria for endemicity to occur could
be met for harbour seals.
There was no regional variation in seroprevalence
across Scotland, indicating that seals in the declining
populations in Orkney and along the East coast have
similar proportions of seropositive seals to the stable
populations along the West coast. In addition, there
has been no change in prevalence over time, even in
declining populations, and none of the seals sampled
in this study showed any overt signs of ill health.
These results further support the hypothesis that they
may be infected by a strain of the bacteria that
appears to be having little effect on their health.
Other pinniped species have also been shown to be
seropositive and yet remain apparently healthy and
asymptomatic (Nielsen et al. 1996, 2005, Retamal et
al. 2000, Nymo et al. 2011). Together, these results
indicate that the bacteria may only cause a mild and
transient infection, and B. pinnipedialis is most likely
not a major cause of the harbour seal decline in Scot-
land. Other potential causes of the declines should
therefore continue to be investigated.
Juveniles showed the highest overall prevalence of
the 3 age classes. It has been reported that the higher
incidence in juveniles may be a result of recent expo-
sure to the pathogen due to a change to a prey-based
diet after they are weaned (Lynch et al. 2011, Nymo et
al. 2013b). Lungworms carrying Brucella in fish prey
species may be a means by which marine mammals
become infected with the bacterium, as was suggested
when Brucella was isolated from the lungworms in a
harbour porpoise Phocoena phocoena (Dawson et al.
2008). Brucella species have also have also been
found by immunohistochemical staining in the uterus
and the intestinal lumen of female Para filaroides
lungworms from a Pacific harbour seal (Garner et al.
1997), and it was postulated that, based on the life
 cycle of the parasite, the larvae migrate through the
respiratory tract and are then swallowed. From there,
they pass through the digestive tract and out into the
environment in the faeces, where they are taken up
by fish and ultimately by the seal. The parasitic larvae
are released into the gastrointestinal tract of the ani-
mal, and when they mature into adults, they migrate
to the lungs and continue the life cycle (Howard et al.
1983). It may also be significant that lung was the
body tissue with the highest isolation rate from the 24
harbour seals that were positive by Brucella culture.
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As such, the high levels of anti bodies in seropositive
juveniles may suggest a more recent exposure to Bru-
cella as they first start to eat fish containing the in-
fected parasites, but it is not necessarily indicative of
an active infection. The sero positive adults have high
antibody levels which may be indicative of both previ-
ous and regular exposure to the bacteria.
The finding that there were lower levels of Brucella
antibodies in the seropositive pups compared to
both seropositive adults and juveniles is surprising. It
would be expected that passively transferred mater-
nal antibodies would be present in pups, as they are
found in the offspring of antibody-positive mothers in
terrestrial species (Ray et al. 1988, Thakur et al. 2002,
Rhyan et al. 2009). However, a lower seroprevalence
was seen in Australian fur seal (Lynch et al. 2011),
Hawaiian monk seal (Aguirre et al. 2007), hooded
seal (Nymo et al. 2013b) and Alaskan harbour seal
pups (Zarnke et al. 2006) compared to both adults
and juveniles. In these studies, it was concluded that
pups may have had maternal antibodies at titres
lower than the threshold of detection used in their
serological tests. These data support the theory that
pups likely have low levels of maternal antibodies
and that they may not be exposed to infection until a
later stage post-weaning (Lynch et al. 2011). These
findings further highlight the need for investigations
into the timing of first exposure to Brucella and sero-
conversion as well as the development of specific
thresh olds of detection for antibodies to marine mam-
mal strains of Brucella in various serological tests.
While the overall proportion of positive seals did not
change across the different sampling regions over
time, there were varying patterns of high and low an-
tibody levels measured in the seropositive seals.
Higher antibody levels were not recorded in the de-
clining populations, however, and there were no pop-
ulations with consistently higher or lower antibody
levels. The presence of antibodies does not necessarily
suggest that the animals had a current or active infec-
tion at the time of sampling. The variation over time
seen here between populations likely re flects cycles
of infection followed by clearance in infected individ-
uals that do not show any clinical signs of the disease.
While the apparently high exposure rates of Scottish
harbour seals to Brucella appear not to be having a
negative impact on their populations, such levels may
have important implications for cross-species infec-
tions between humans and domestic livestock, where
infections may lead to disease. Currently, a total of 53
marine mammal species worldwide have been shown
to be seropositive for Brucella antibodies, and 20 of
these species have been positive for B. ceti or B pinni-
pedialis by culture or PCR assays (Hernández-Mora
et al. 2013, Foster et al. 2015). The high seropreva-
lence seen here in all populations across Scotland
suggests that wildlife professionals working with live
seals could be ex posed to the bacterium, and care
should be taken when handling the animals and
working with samples. To date, there have been 4
documented cases of humans infected with B. ceti
(Brew et al. 1999, Sohn et al. 2003, McDonald et al.
2006), demonstrating the zoonotic potential of that
species, but human infections with B. pinnipedialis
have not been documented.
In conclusion, over one-quarter of Scottish harbour
seals have detectable levels of antibodies to Brucella
which may indicate endemicity in these populations,
possibly to a strain of the pathogen that has little
effect on the health of individuals. These prevalence
rates do not appear to explain the declines in Orkney
and along the East coast as the prevalence in these
areas is the same as in populations along the West
coast that remain stable. The causes of the decline
are likely to vary between regions and are probably
due to a combination of factors, but Brucella infection
does not appear to be one of them, based on our find-
ings and comparison with seroprevalence rates for
Scottish harbour seals before 2002 (Foster et al.
2002). Despite the routine use of the serological tests
used here in many assessments of exposure to Bru-
cella species, further validation of the tests for marine
mammals is needed, and the discrepancies between
the 2 test types here highlight the need for careful
interpretation of the results.
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